Non-Adherence in clinical trials can cause a multitude of consequences - for the patient, for the pharmaceutical company and for society. Our guest Jesper Hassel explains many facets of this dilemma and give some insights on how adherence can be monitored.

For further information on Mevias solution please contact:
www.mevia.se
[email protected]

You can also contact us on:
[email protected]